Mylan (MYL), Actavis (ACT) Continue Lower Following CVS/Cardinal Health Agreement
Get Alerts CVS Hot Sheet
Join SI Premium – FREE
Mylan (Nasdaq: MYL), Actavis (NYSE: ACT) are lower Tuesday following CVS (NYSE: CVS) and Cardinal Health (NYSE: CAH) reaching a new generic sourcing entity agreement with Cardinal Health, which is said to be the largest in the U.S.
Mylan is down 3.4 percent, while Actavis is down 2.5 percent.
Mylan is down 3.4 percent, while Actavis is down 2.5 percent.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alibaba's (BABA) Ant Group Appoints Han Xinyi as President - Reuters
- XPeng Inc. (XPEV) Terminates Relevant Agreement with Taobao China
- US Energy Department Set To Unveil Final Rules On Tuesday That Will Soften Proposal To Slash Electric Vehicle Mileage Ratings To Meet Fuel Economy Rules - Reuters
Create E-mail Alert Related Categories
Insiders' Blog, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!